双重血浆吸附系统成功救治甲状腺功能亢进危象合并肝、心衰竭1例报告

王涛; 李凤惠; 梁静

doi:10.3969/j.issn.1001-5256.2021.05.039

双重血浆吸附系统成功救治甲状腺功能亢进危象合并肝、心衰竭1例报告

DOI: 10.3969/j.issn.1001-5256.2021.05.039

天津医科大学三中心临床学院，天津市第三中心医院肝内科，天津市人工细胞重点实验室，天津市肝胆疾病研究所，卫生部人工细胞工程技术研究中心，天津 300170

利益冲突声明：所有作者均声明不存在利益冲突。

作者贡献声明：王涛、李凤惠负责收集整理数据，资料分析，撰写论文；梁静负责拟定写作思路。

详细信息

作者简介:
王涛(1984—)，男，主治医师, 主要从事肝硬化相关并发症的诊治研究

通信作者:
梁静, haolele77@Sina.com

中图分类号: R575.3
计量
- 文章访问数: 465
- HTML全文浏览量: 154
- PDF下载量: 31
- 被引次数: 0
出版历程
- 收稿日期: 2020-10-22
- 录用日期: 2020-12-10
- 出版日期: 2021-05-20

Successful treatment of thyroid storm with liver failure and heart failure using the double plasma molecular absorption system: A case report

The Third Central Clinical College of Tianjin Medical University, Department of Gastroenterology and Hepatology, The Third Central Hospital of Tianjin, Tianjin Key Laboratory of Artificial Cells, Tianjin Institute of Hepatobiliary Disease, Artificial Cell Engineering Technology Research Center of Public Health Ministry, Tianjin 300170, China

摘要

- 甲状腺功能亢进症 /
- 甲状腺危象 /
- 肝功能衰竭 /
- 心力衰竭
- Hyperthyroidism /
- Thyroid Crisis /
- Liver Failure /
- Heart Failure

HTML全文

图 1 肝穿刺活检病理染色(HE染色，×200)

注：a，汇管区炎症细胞浸润；b，肝窦扩张伴灶性胆栓形成。

下载: 全尺寸图片幻灯片

图 2 TBil及凝血功能变化趋势

下载: 全尺寸图片幻灯片

表 1 4次DPMAS治疗前后胆红素及凝血功能变化

时间	体温(℃)	心率(次/min)	TBil(μmol/L)	DBil(μmol/L)	TBA(μmol/L)	PTA(%)	INR
第1次
治疗前	38.6	150	488.4	346.6	151.0	68	1.28
治疗后	37.6	120	279.8	183.8	87.7	25	3.03
第2次
治疗前	37.3	116	167.4	90.9	209.3	69	1.26
治疗后	36.8	90	123.0	53.4	110.2	21	3.53
第3次
治疗前	37.8	105	120.9	56.1	291.0	79	1.19
治疗后	35.9	88	91.2	37.6	131.8	26	2.89
第4次
治疗前	36.5	97	97.5	41.5	105.0	106	0.96
治疗后	36.2	73	71.5	23.1	71.1	39	1.96

下载: 导出CSV

参考文献(15)

[1]	HABERSHON SO. Exophthalmic goiter, heart disease, jaundice, death[J]. Lancet, 1874, 103(2641): 510-512.
[2]	NING XJ, HE LL, ZHOU Q, et al. A case of cardiogenic cirrhosis due to long - term hyperthyroidism[J]. J Clin Hepatol, 2018, 34(4): 840-841. DOI: 10.3969/j.issn.1001-5256.2018.04.029. 宁秀景, 何丽丽, 周琦, 等. 长期甲状腺功能亢进致心源性肝硬化1例报告[J]. 临床肝胆病杂志, 2018, 34(4): 840-841. DOI: 10.3969/j.issn.1001-5256.2018.04.029.
[3]	LIN TY, SHEKAR AO, LI N, et al. Incidence of abnormal liver biochemical tests in hyperthyroidism[J]. Clin Endocrinol (Oxf), 2017, 86(5): 755-759. DOI: 10.1111/cen.13312.
[4]	JING J, LUO SQ, GONG M, et al. Case of subacute liver failure due to hyperthyroidism[J]. J Clin Hepatol, 2013, 29(9): 707-708. DOI: 10.3969/j.issn.1001-5256.2013.09.019. 景婧, 罗生强, 宫嫚, 等. 甲状腺功能亢进症致亚急性肝衰竭1例报告[J]. 临床肝胆病杂志, 2013, 29(9): 707-708. DOI: 10.3969/j.issn.1001-5256.2013.09.019.
[5]	KUBOTA S, AMINO N, MATSUMOTO Y, et al. Serial changes in liver function tests in patients with thyrotoxicosis induced by Graves' disease and painless thyroiditis[J]. Thyroid, 2008, 18(3): 283-287. DOI: 10.1089/thy.2007.0189.
[6]	Liver Failure and Artificial Liver Group, Chinese Society of Infectious Diseases, Chinese Medical Association; Severe Liver Disease and Artificial Liver Group, Chinese Society of Hepatology, Chinese Medical Association. Guideline for diagnosis and treatment of liver failure(2018)[J]. J Clin Hepatol, 2019, 35(1): 38-44. DOI: 10.3969/j.issn.1001-5256.2019.01.007. 中华医学会感染病学分会肝衰竭与人工肝学组, 中华医学会肝病学分会重型肝病与人工肝学组. 肝衰竭诊治指南(2018年版)[J]. 临床肝胆病杂志, 2019, 35(1): 38-44. DOI: 10.3969/j.issn.1001-5256.2019.01.007.
[7]	MALIK R, HODGSON H. The relationship between the thyroid gland and the liver[J]. QJM, 2002, 95(9): 559-569. DOI: 10.1093/qjmed/95.9.559.
[8]	BOELAERT K, NEWBY PR, SIMMONDS MJ, et al. Prevalence and relative risk of other autoimmune diseases in subjects with autoimmune thyroid disease[J]. Am J Med, 2010, 123(2): 183. e1-9. DOI: 10.1016/j.amjmed.2009.06.030.
[9]	KHEMICHIAN S, FONG TL. Hepatic dysfunction in hyperthyroidism[J]. Gastroenterol Hepatol (N Y), 2011, 7(5): 337-339. http://europepmc.org/abstract/MED/21857837
[10]	PIANTANIDA E, IPPOLITO S, GALLO D, et al. The interplay between thyroid and liver: Implications for clinical practice[J]. J Endocrinol Invest, 2020, 43(7): 885-899. DOI: 10.1007/s40618-020-01208-6.
[11]	MULLER C, PERRIN P, FALLER B, et al. Role of plasma exchange in the thyroid storm[J]. Ther Apher Dial, 2011, 15(6): 522-531. DOI: 10.1111/j.1744-9987.2011.01003.x.
[12]	SATOH T, ISOZAKI O, SUZUKI A, et al. 2016 Guidelines for the management of thyroid storm from The Japan Thyroid Association and Japan Endocrine Society (First edition)[J]. Endocr J, 2016, 63(12): 1025-1064. DOI: 10.1507/endocrj.EJ16-0336.
[13]	THUMMA S, MANCHALA V, MATTANA J. Radiocontrast-induced thyroid storm[J]. Am J Ther, 2019, 26(5): e644-e645. DOI: 10.1097/MJT.0000000000000844.
[14]	ASHKAR FS, KATIMS RB, SMOAK WM 3rd, et al. Thyroid storm treatment with blood exchange and plasmapheresis[J]. JAMA, 1970, 214(7): 1275-1279. DOI: 10.1001/jama.1970.03180070041007
[15]	PUY H, LAMORIL J, MARCELLI JM, et al. Thyroid hormone extraction by plasma exchange: A study of extraction rate[J]. Biomed Pharmacother, 1992, 46(9): 413-417. DOI: 10.1016/0753-3322(92)90046-a.